Biotricity receives Nasdaq delisting notice; trading suspended August 5, 2024

BIOTRICITY INC.

Nasdaq Hearings Panel determined to delist Biotricity's common stock; trading suspended at open Aug 5, 2024.
Non-compliance with minimum $35M market value of listed securities (MVLS) rule; compliance deadline extended to July 29, 2024.
Company expects stock to be quoted on OTC Pink under symbol BTCY; also applied to OTCQB.
Company has 15 days to request review of Panel's decision by Nasdaq Listing and Hearing Review Council.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.